Dew was on record as stating that V would not be as successful as bulls anticipate, particularly noting that it required taking 4 pills p e r day

Gg. Dndn may be the most manipulated stocks in history. SEC did nothing.

When will final details and documents for upcoming FDA Nov meeting be published

Duke, would it be appropriate for you to post your email so others can use it as a template to follow suit

Whal. Thanks for refinement. Was concentrating on Mace reduction endpoint

RVX study population mirrors V population ie. Reduction of mace events. I believe they would not be on AHA agenda unless results are positive. As good as V ??? I have a few thousand shares. Not a big stake.

Rvxcf accepted for AHA presentation. Top line results to be announced before Sept. 30. This appears to be legitimate competition. Obviously different approach /moa, but addressing same issues

BOM ph3 should use 3 U.S. sites and 1 EU site. This could be a very quick study. There would be no shortage of patients. Design and follow up is already defined. Let's get the ball rolling. Don't need a 12 cohort approach here

I believe the FDA is trying to put as much pressure on Amrn as possible to negotiate a tighter label. They despise the company and the institutional memory is strong. When is the last time the FDA scheduled a Pdufa date on a holiday weekend at the end of the year, leaving no time for the stock. Market to react or the insurance companies time to adjust 2020 guidelines

I'd lynas talking to the pentagon about supplying rare earth metals from Australia project

Baker bros. Also in mrkr

Leo made an outstanding deal. Partnership provides immediate funds for internal development and future revenue stream. Buying again. Dud , you have any shares for sale

That was Mace events are increasing since 2010

JAMA article. Mace meets increasing since 2010, after long period of decine

Rvxcf data to be presented at major European conference in next week. Mace event reduction via epigenetic approach is the key outcome of P3. Don't know if this will be competOrion for V approach to Mace reduction.

Zum. Does Amrn need a big name endo + bhattman to make a presentation now or at pdufa?

Dan, it was an outrage that CEO sold $10million of stock in one day after results announced. There should have been some restrictions. He sold at$23, perhaps he could repurchase a little at 15.

JL condolences. Thanks for all you've done here

Waiting for Godot was less exasperating. It's time for some information

JL. I couldn't disagree more. Warren et al would be the first to support a new drug with V scientific and cost profile. FDA is doing this on their own or with some pushing from the big pharma lobby.

FDA has never believed in V science. Additionally, they have nothing but disdain for the company(for having the audacity to challenge them in court). They will delay as long as possible. They may even ask for a quick Montreal oil study. In the end Amrn will prevaol.

No. Manipulators have spoken. True investors see opportunity. Fly longs

Thanks Leo. As a conspiracy theorist I wonder if some word leaked last week when the stock went down for no reason. Shorts will continue to try to hold the stock price,but progress on any front,(bom, v, etc.) Will help us get to a dollar

Next deal oral B

This is just the first deal. Duds friends will try to hold apps down. UNsuccessfully

Couldn't get thru. Any update info appreciated

Raf They may have executed well to date. The question is do they have the right strategy going forward? No one on the current team has the experience or expertise to build and run a multi billion dollar pharma. Is gia the right strategy? What about Europe and Asia? I'm from Missouri on this one.

Would Goldman invite AMRN to present at their conference, then underwrite a secondary and market it to their clients without having the inside track on upcoming FDA review? They are a greedy, ruthless firm, but they are not stupid or suicidal. This process has shaken loose the last of the weak hands. Good luck from here. Thanks tp JL, BB and others who helped me buy and add to this stock over the last 5 years. I did sell some when results came out, but need the remainder to fund some 529 accounts

Now entering the DrunkenSailor stage. Management feels they have an unlimited piggy bank and they can do anything. watch out for Beer muscle Mentality and frivolous spending

Does anyone follow resveralogix? Trying to confirm P3 results and publication in a recognized journal

Dud why would anyone take hours of their time to research and write an article on a 20cent stock? Manipulation would be the only reason. I would view such an article as a positive indicator

CBB I hope you are correct. I saw that their phase3 results were already accepted for publication on a recognized journal??

Does resveralogix product compete with V or is it complimentary?

DEATH WATCH. That's what the FDA has forced heart patients to endure ever since they reneged on their agreement. Thousands of people die each day from mace events, preventable mace events. Every day the FDA sits on their hands they literally kill thousands. Death watch for those poor folks.

Yes please list FALSE prs

High options volume. Someone is looking at the company

Amrn is Najarian presentation cnbc

Spoke to someone in 5g business. He couldn't stop talking about American tower and crown. Busy beyond ant expectation with 5g set up

Fabio it means md. Can write rx for vacepa and the insurance company will pay. Now payment is limited

After successful FDA label extension the will obviously rise. Only at that point will a big pharma CEO be able to offer a reasonable acceptable offer for AMRN. No CEO is able to offer $50+ for AMRN pre label expansion , but he will be able to make that offer when the stock is at 30 and derisked